• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season

tetano

Editor, Senior Moderator
Vaccine. 2018 Aug 6. pii: S0264-410X(18)31074-0. doi: 10.1016/j.vaccine.2018.07.065. [Epub ahead of print]
[h=1]Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016/17 season.[/h] Shinjoh M[SUP]1[/SUP], Sugaya N[SUP]2[/SUP], Yamaguchi Y[SUP]3[/SUP], Iibuchi N[SUP]4[/SUP], Kamimaki I[SUP]5[/SUP], Goto A[SUP]6[/SUP], Kobayashi H[SUP]7[/SUP], Kobayashi Y[SUP]8[/SUP], Shibata M[SUP]9[/SUP], Tamaoka S[SUP]10[/SUP], Nakata Y[SUP]11[/SUP], Narabayashi A[SUP]12[/SUP], Nishida M[SUP]13[/SUP], Hirano Y[SUP]14[/SUP], Munenaga T[SUP]6[/SUP], Morita K[SUP]14[/SUP], Mitamura K[SUP]15[/SUP], Takahashi T[SUP]1[/SUP]; Keio Pediatric Influenza Research Group.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] We assessed the vaccine effectiveness (VE) of inactivated influenza vaccine (IIV) in children 6 months to 15 years of age during the 2016/17 season. In addition, we estimated the impact of repeated vaccination in children on VE.
[h=4]METHODS:[/h] Our study for VEs in preventing influenza and admission due to influenza were conducted according to a test-negative case-control design (TNCC) based on influenza rapid diagnostic test results. We also analyzed the VE by vaccine status in the current and previous seasons for the impact of repeated vaccination.
[h=4]RESULTS:[/h] During the 2016/17 season, the quadrivalent IIV was used in Japan. The adjusted VE in preventing influenza illness was 38% (95% CI, 29-46) against influenza A and 39% (95% CI, 18-54) against influenza B. Infants showed no significant VE. The VE in preventing hospitalization was not demonstrated. For the analysis of repeated vaccination, the vaccine was effective only when immunization occurred in the current season. The children who were immunized in two consecutive seasons were more likely to develop influenza compared to those immunized in the current season only (odds ratio, 1.58 [95% CI, 1.05-2.38], adjusted odds ratio, 1.53 [95% CI, 0.99-2.35]). However, the odds ratio of repeated vaccination was not significant when the analysis excluded those who developed influenza in the previous season.
[h=4]CONCLUSIONS:[/h] VE in children in the 2016/17 season was similar to values previously reported. Repeated vaccination interfered with the VE against any influenza infection in the 2016/17 season. The results of our study suggest that decreased VE by repeat vaccination phenomenon was associated with immunity by influenza infection in the previous season. However, the influenza vaccine should be recommended every season for children.
Copyright ? 2018. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Children; Effectiveness; Hospitalization; Influenza vaccine; Repeated vaccination; Test-negative case control design

PMID: 30093289 DOI: 10.1016/j.vaccine.2018.07.065
 
Back
Top Bottom